The forecast data for blood and blood-forming organs medicine use in Belgium from 2024 to 2028 shows a gradual increase in the Defined Daily Dosage (DDD) per thousand persons per day. Starting at 117.1 units in 2024, there is a slight yearly increase, reaching 118.1 units by 2028. This represents a consistent yet modest growth trend over the five-year period, with an average annual growth rate of approximately 0.21%. This steady increase suggests a controlled rise in the demand for these medicines, likely reflecting a stable growth in the patient population requiring blood and blood-forming organ treatments.
Looking ahead, key trends to monitor include advancements in treatment methods, shifts in demographic profiles, and changes in healthcare policies. Innovations in medical treatments could alter demand patterns, while an aging population is likely to increase the need for such medications. Healthcare policy changes, including funding and reimbursement adjustments, could also significantly impact medicine use trends.
